Sustainability is More than Green Power

As governments and corporations look for ways to reduce their carbon footprint, Eric Dunford, Director of Sustainability for CarbonCure, knows of a solution to help these entities meet their needs when it comes to construction projects.

Dunford joined host Raymond Hawkins to talk about CarbonCure’s process for introducing recycled CO2 Into fresh concrete to reduce its carbon footprint without compromising performance.

One of the challenges to achieving sustainability in concrete is the cementing agent, which provides approximately 90% of the carbon emissions from the material.

“The process necessary to create cement causes a chemical reaction that generates CO2,” Dunford said. “What CarbonCure is doing is taking a portion of CO2 from a post-industrial source, reintroducing it to concrete as it is mixed at the plant, and, as a result of that reintroduction, it will then chemically reform back as calcium carbonate or limestone.”

This process reclaims CO2 that would typically go into the atmosphere and traps it into the concrete, where it will stay in an embedded form for the entire lifespan of that structure.

Dunford notes the CarbonCure process doesn’t 100% eliminate CO2 from the production process of cement. Still, it does take away a portion of generated CO2 destined to be a pollutant. It uses it in a way that benefits the creation of concrete while lowering overall carbon footprint.

An added benefit to concrete made with the CarbonCure process is the injected carbon strengthens the concrete.

“By using this approach, you can use less raw materials and make the same end product in concrete,” Dunford said.

Be sure to subscribe to our industry publication for the latest news, videos, and podcasts in the Software and Technology Industry.

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More